FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

323125001: Co-careldopa 50mg/200mg m/r tablet (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2006. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    464820019 Co-careldopa 50mg/200mg m/r tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1190012012 Co-careldopa 50mg/200mg m/r tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    464820019 Co-careldopa 50mg/200mg m/r tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    464820019 Co-careldopa 50mg/200mg m/r tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    717340017 Co-careldopa 50mg/200mg m/r tablet (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1190012012 Co-careldopa 50mg/200mg m/r tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1190012012 Co-careldopa 50mg/200mg m/r tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Co-careldopa 50mg/200mg m/r tablet Is a Co-careldopa false Inferred relationship Existential restriction modifier (core metadata concept)
    Co-careldopa 50mg/200mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Carbidopa false Inferred relationship Existential restriction modifier (core metadata concept)
    Co-careldopa 50mg/200mg m/r tablet Is a Carbidopa + levodopa 50mg/200mg m/r tablet false Inferred relationship Existential restriction modifier (core metadata concept)
    Co-careldopa 50mg/200mg m/r tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
    Co-careldopa 50mg/200mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Levodopa (substance) false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    GB English

    US English

    POSSIBLY EQUIVALENT TO association reference set

    REPLACED BY association reference set (foundation metadata concept)

    SAME AS association reference set (foundation metadata concept)

    Back to Start